EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL)
Beshara, E., Sharaf, A., Wahba, N. (2021). EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL). EKB Journal Management System, 46(Issue 1), 153-160. doi: 10.21608/adjalexu.2021.144848
Emmanuella R. Beshara; Aly A. Sharaf; Nadia A. Wahba. "EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL)". EKB Journal Management System, 46, Issue 1, 2021, 153-160. doi: 10.21608/adjalexu.2021.144848
Beshara, E., Sharaf, A., Wahba, N. (2021). 'EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL)', EKB Journal Management System, 46(Issue 1), pp. 153-160. doi: 10.21608/adjalexu.2021.144848
Beshara, E., Sharaf, A., Wahba, N. EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL). EKB Journal Management System, 2021; 46(Issue 1): 153-160. doi: 10.21608/adjalexu.2021.144848

EFFECT OF PHENTOLAMINE MESYLATE ON THE INCIDENCE OF SELF-INFLICTED SOFT TISSUE INJURY FOLLOWING INFERIOR ALVEOLAR NERVE BLOCK ANESTHESIA IN CHILDREN: (RANDOMIZED CONTROLLED CLINICAL TRIAL)

Alexandria Dental Journal
Article 3, Volume 46, Issue 1, April 2021, Page 153-160  XML PDF (299.61 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2021.144848
View on SCiNiTO View on SCiNiTO
Authors
Emmanuella R. Beshara email 1; Aly A. Sharaf2; Nadia A. Wahba2
1Bachelor of Dentistry, Faculty of Dentistry, Alexandria University, Alexandria, Egypt.
2Professor of Pediatric Dentistry, Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Alexandria, Egypt.
Abstract
INTRODUCTION:One of the shortcomings of local anesthesia (LA) is that the soft tissue anesthesia (STA) typically lasts for 3 to 5 hours while most routine dental procedures are completed in less than an hour. Pediatric patients particularly may accidently bite on their lips.
OBJECTIVES: The study was conducted to evaluate the effectiveness of phentolamine mesylate (PM) on the reduction of the incidence of self-inflicted soft tissue injury (STI) and its effect on the time of return of normal function, after inferior alveolar nerve block anesthesia.
MATERIALS AND METHODS: The study is a blinded randomized controlled parallel group clinical trial with a 1:1 allocation ratio. A total of eighty pediatric patients, with an age range of 5-8 years, selected from the Pediatric Dentistry out-patient clinic, Faculty of Dentistry, Alexandria University, after obtaining necessary consents. Inferior alveolar nerve block anesthesia (2 percent lidocaine with 1:100,000 epinephrine) was administered in the recommended dose. After completion of the operative procedure, participants were randomly allocated into 2 groups: study and control group. The experimental group received a PM injection using the same technique employed for administration of LA, in a cartridge ratio of 1:1. The control group did not receive any reversal agent. The incidence of self-inflicted STA and return to normal function were recorded post-operatively and STI was followed up after 24 hours.
RESULTS: There were no significant differences in the incidence of self-inflicted STI between the PM and control group except for the occurrence of ulcers after 24 hours (P=0.04). Phentolamine mesylate accelerated the median time of return to normal function (P =0.001).
CONCLUSION: Phentolamine mesylate was efficacious in reducing the incidence of self-inflicted soft-tissue ulceration and accelerated the time of return to normal function after LA.
Keywords
Local anesthesia; Phentolamine mesylate; Soft tissue ulcer
References
1. Malamed SF. Local anesthetics: Dentistry’s most important drugs, clinical update 2006. J Calif Dent Assoc. 2006;34:971-6.
2. Malamed SF. Handbook of local anesthesia-e-book. 7th ed. London: Elsevier Health Sciences; 2019. p 1-443.
3. Malamed SF. Local anesthesia. J Calif Dent Assoc.1998;26:657, 660.
4. American Dental Association (ADA). 2002 Survey of Dental Practice-Characteristics of Dentists in Private Practice and Their Patients. American Dental Association (ADA); Chicago, IL. 2004.
5. Hersh EV, Moore PA, Saraghi M. Phentolamine mesylate: pharmacology, efficacy, and safety. Gen Dent. 2019;67:12-7.
6. College C, Feigal R, Wandera A, Strange M. Bilateral versus unilateral mandibular block anesthesia in a pediatric population. Pediatr Dent. 2000;22:453-7.
7. Staman NM, Townsend JA, Hagan JL. Observational study: discomfort following dental procedures for children. Pediatr Dent. 2013;35:52-4.
8. Katyal V. The efficacy and safety of articaine versus lignocaine in dental treatments: a meta-analysis. J Dent. 2010;38:307-17.
9. Yapp KE, Hopcraft MS, Parashos P. Articaine: a review of the literature. Br Dent J. 2011;210:323-9.
10.Moore PA, Hersh EV, Papas AS, Goodson JM, Yagiela JA, Rutherford B, et al. Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylate. Anesth Prog. 2008;55:40-8.
11.Leimdorfer A. Prevention and abolition of cardiac arrhythmias by regitine (C-7337). Am J Physiol. 1952; 171:742-3. Quoted from: Malamed SF. Reversing local anesthesia. Inside Dentistry. 2008;4:2-3.
12.McNeil C, Copeland J. Accidental digital epinephrine injection: to treat or not to treat? Can Fam Physician. 2014;60:726-8.
13.Zentgraf M, Ludwig G, Ziegler M. How safe is the treatment of impotence with intracavernous autoinjection? Eur Urol. 1989;16:165-71.
14.Goswami A, Bora A, Kundu GK, Ghosh S. Reversal of Residual Soft-Tissue Anesthesia : 2014;2:86-9.
15.FDA approves OraVerse for pediatric dental patients 3 years and older. 2016. Available at: https://www.fda.gov/files/drugs/published/N22-159S011-Phentolamine-mesylate-Clinical-PREA.pdf. Accessed November 27, 2019.
16.Hersh EV, Lindemeyer R, Berg JH, Casamassimo PS, Chin J, Marberger A, et al. Phase four, randomized, double-blinded, controlled trial of phentolamine mesylate in two- to five-year-old dental patients. Pediatr Dent. 2017;39:39-45.
17.Vinnakota DN, Kamatham R. Safety profile of phentolamine mesylate as reversal agent of pulpal and soft tissue dental anesthesia: a systematic review and meta-analysis. Quintessence Int. 2019;50:568-75.
18.Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726-32.
19.Tavares M, Goodson JM, Studen-Pavlovich D, Yagiela JA, Navalta LA, Rogy S, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients. J Am Dent Assoc. 2008;139:1095-104.

20.Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;13:1-10.
21.Killeen PR. An Alternative to Null-Hypothesis Significance Tests. Psychol Sci. 2005;16:345-53.
22.Daniel W. Biostatistics. A foundation for analysis in the health science. 9th ed. Chichester: Wiley; 2008. p.2-699.
23.Pannucci CJ, Wilkins EG. Identifying and Avoiding Bias in Research. Plast Reconstr Surg. 2010;126:619-25.
24.Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175-91.
25.Doyle DJ, Garmon EH. American Society of Anesthesiologists classification (ASA class). StatPearls Publishing; 2019.
26.Frankl SN. Should the parent remain with the child in the dental operatory? J Dent Child. 1962;29:150-63.
27.Kim J, Shin W. How to do random allocation (randomization). Clin Orthop Surg. 2014;6:103-9.
28.Nourbakhsh N, Shirani F, Babaei M. Effect of phentolamine mesylate on duration of soft tissue local anesthesia in children. J Res Pharm Pr. 2012;1:55-9.
29.Fisher HB, Logemann JA. The Fisher-Logemann test of articulation competence. Boston, Houghton Mifflin; 1971. Quoted from: Hersh EV, Moore PA, Papas AS, Goodson JM, Navalta LA, Rogy S, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc. 2008;139:1080-93.
30.DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol. 1992;49:1259-61.
31.Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274:1456-8.
32.Septodont Inc. OraVerse (Phentolamine Mesylate) Drug Package Insert. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022159s011lbl.pdf. Accessed November 27, 2019.
33.Boynes SG, Riley AE, Milbee S, Bastin MR, Price ME, Ladson A. Evaluating complications of local anesthesia administration and reversal with phentolamine mesylate in a portable pediatric dental clinic. Gen Dent. 2013;61:70-6.
34.Hersh EV, Moore PA, Papas AS, Goodson JM, Navalta LA, Rogy S, et al. Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adults. J Am Dent Assoc. 2008;139:1080-93.

Statistics
Article View: 393
PDF Download: 576